Vortioxetine for Menopausal Depression and Associated Symptoms

Trial Profile

Vortioxetine for Menopausal Depression and Associated Symptoms

Phase of Trial: Phase IV

Latest Information Update: 08 May 2017

At a glance

  • Drugs Vortioxetine (Primary)
  • Indications Depressive disorders; Menopause
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Mar 2017 Status changed from recruiting to completed.
    • 16 Mar 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jul 2016 as per ClinicalTrials.gov record.
    • 29 Oct 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top